X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (647) 647
Publication (67) 67
Book Chapter (36) 36
Book Review (8) 8
Dissertation (4) 4
Book / eBook (3) 3
Conference Proceeding (2) 2
Government Document (2) 2
Web Resource (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (346) 346
index medicus (326) 326
female (210) 210
immunology (163) 163
animals (162) 162
vaccination (160) 160
vaccines (147) 147
cervical cancer (121) 121
human papillomavirus (115) 115
cancer (96) 96
prophylactic vaccine (96) 96
infection (95) 95
prophylactic (93) 93
prevention (89) 89
immunization (88) 88
papillomavirus infections - prevention & control (88) 88
vaccine (86) 86
adult (84) 84
health aspects (84) 84
medicine, research & experimental (80) 80
mice (80) 80
male (74) 74
prophylactic vaccines (71) 71
adolescent (66) 66
oncology (65) 65
papillomavirus infections (64) 64
virus-like particles (61) 61
research (59) 59
uterine cervical neoplasms - prevention & control (59) 59
immunogenicity (55) 55
papillomavirus vaccines - immunology (55) 55
antigens (54) 54
infections (52) 52
particle vaccine (52) 52
prophylactic vaccination (51) 51
care and treatment (50) 50
double-blind (49) 49
immunotherapy (49) 49
pharmacology & pharmacy (48) 48
young-women (48) 48
antibodies (47) 47
hpv (45) 45
immunity (45) 45
infectious diseases (45) 45
article (43) 43
papillomavirus vaccines - administration & dosage (43) 43
child (42) 42
efficacy (42) 42
therapeutic (42) 42
viruses (42) 42
clinical trials (41) 41
analysis (40) 40
middle aged (40) 40
young adult (40) 40
risk factors (38) 38
immune-responses (37) 37
mice, inbred balb c (37) 37
microbiology (37) 37
proteins (37) 37
uterine cervical neoplasms - virology (37) 37
public health (36) 36
review (36) 36
women (36) 36
immune response (35) 35
allergy and immunology (34) 34
medicine, general & internal (32) 32
cervical-cancer (31) 31
diagnosis (31) 31
virus diseases (31) 31
biotechnology & applied microbiology (30) 30
dendritic cells (30) 30
disease models, animal (30) 30
randomized controlled-trial (30) 30
disease (29) 29
epidemiology (29) 29
papillomaviridae - immunology (29) 29
papillomavirus infections - virology (29) 29
prophylactic immunization (29) 29
cervical intraepithelial neoplasia (28) 28
clinical trials as topic (28) 28
medical research (28) 28
therapeutic vaccine (28) 28
aged (27) 27
papillomavirus infections - immunology (27) 27
prophylactic efficacy (27) 27
t-cells (27) 27
dna vaccine (26) 26
virology (26) 26
antibodies, viral - blood (25) 25
cancer vaccines (25) 25
papillomavirus vaccines - therapeutic use (25) 25
prophylactic treatment (25) 25
safety (25) 25
chemotherapy (24) 24
human-papillomavirus type-16 (24) 24
medicine & public health (24) 24
responses (24) 24
follow-up (23) 23
intraepithelial neoplasia (23) 23
papillomavirus infections - complications (23) 23
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (632) 632
German (15) 15
French (12) 12
Spanish (9) 9
Japanese (5) 5
Czech (3) 3
Korean (3) 3
Polish (3) 3
Russian (3) 3
Portuguese (2) 2
Chinese (1) 1
Hungarian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Pediatric Infectious Disease Journal, ISSN 0891-3668, 07/2016, Volume 35, Issue 7, pp. e206 - e219
BACKGROUND:Immune responses and safety profiles may be affected when vaccines are coadministered. We evaluated the immunogenicity, safety and reactogenicity of... 
IMMUNE-RESPONSE | INFECTIOUS DISEASES | BACTERIA | booster vaccination | DTPa-IPV-Hib coadministration | HAEMOPHILUS-INFLUENZAE | IMMUNOLOGY | CHILDHOOD VACCINES | immunogenicity | NASOPHARYNGEAL CARRIAGE | 10-valent pneumococcal conjugate vaccine | PROPHYLACTIC PARACETAMOL | STREPTOCOCCUS-PNEUMONIAE | reactogenicity | DISEASE | PEDIATRICS | NETHERLANDS | PHID-CV | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Vaccines, Conjugate - adverse effects | Child, Preschool | Infant | Male | Haemophilus Vaccines - administration & dosage | Pneumococcal Vaccines - administration & dosage | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Poliovirus Vaccine, Inactivated - immunology | Immunoglobulin D - immunology | Vaccines, Conjugate - immunology | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Pneumococcal Infections - immunology | Immunization, Secondary | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Female | Pneumococcal Vaccines - adverse effects | Antibodies, Bacterial - blood | Diphtheria-Tetanus-Pertussis Vaccine - adverse effects | Hepatitis B Vaccines - administration & dosage | Haemophilus Vaccines - immunology | Vaccines, Conjugate - administration & dosage | Vaccines, Combined - adverse effects | Hepatitis B Vaccines - adverse effects | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - immunology | Poliovirus Vaccine, Inactivated - adverse effects | Antibodies, Viral - immunology | Hepatitis B Vaccines - immunology
Journal Article
1999, 3rd ed., ISBN 0721674437, xix, 1230
Book
FRONTIERS IN IMMUNOLOGY, ISSN 1664-3224, 07/2018, Volume 9
Lymphatic filariasis (LF) is a tropical parasitic infection of human transmitted by mosquitoes. Chronic infection results in severe physical disability in the... 
PARASITES | TLR-4 | mouse model | EFFICACY | THIOREDOXIN PEROXIDASE | CANDIDATE | aluminum | IMMUNOLOGY | prophylactic vaccine | BRUGIA-MALAYI | lymphatic filariasis | multivalent antigen | IMMUNE-RESPONSES | MULTIVALENT VACCINE | MULTIPLE ANTIGEN | MOLECULAR-CLONING | INFECTION | Prevention | Usage | Filariasis | Rattus | Rats | Models | Vaccines
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 30, Issue 5, pp. F123 - F138
Highlights ► The analyses of human papilloma virus/virus-like particle vaccine phase III efficacy trials in young women are largely completed. ► High efficacy... 
Allergy and Immunology | Prophylactic vaccine | Genital warts | Virus-like particle | Gardasil | Clinical trials | VaIN | CIN | VIN | Cervical cancer | HPV | Cervarix | Vain | Cin | Vin | Hpv | MEDICINE, RESEARCH & EXPERIMENTAL | Cervarix (R) | (HPV)-16/18 AS04-ADJUVANTED VACCINE | OF-STUDY ANALYSIS | Gardasil (R) | CERVICAL-CANCER | IMMUNOLOGY | GRADE 3 | IMMUNOGENICITY | PARTICLE VACCINE | DOUBLE-BLIND | POOLED ANALYSIS | YOUNG-WOMEN | HPV TYPES | Vaccines, Virus-Like Particle - adverse effects | Papillomavirus Infections - complications | Humans | Condylomata Acuminata - virology | Uterine Cervical Neoplasms - prevention & control | Vulvar Neoplasms - virology | Anus Neoplasms - prevention & control | Anus Neoplasms - virology | Male | Vaginal Neoplasms - virology | Condylomata Acuminata - prevention & control | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Clinical Trials, Phase III as Topic | Vaccines, Virus-Like Particle - administration & dosage | Papillomavirus Infections - prevention & control | Vaginal Neoplasms - prevention & control | Vulvar Neoplasms - prevention & control | Papillomavirus Vaccines - adverse effects | Uterine Cervical Neoplasms - virology | Female | Papillomavirus Vaccines - immunology | Vaccines, Virus-Like Particle - immunology | Papillomavirus Vaccines - administration & dosage | Dysplasia | Care and treatment | Oncology, Experimental | Vaccines | Research | Papillomaviruses | Warts | Health aspects | Papillomavirus infections | Public health | Cancer | Human papillomavirus
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 3/2010, Volume 102, Issue 5, pp. 325 - 339
Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital... 
AGED 16-26 YEARS | QUADRIVALENT VACCINE | ONCOLOGY | NEUTRALIZING EPITOPES | CLINICAL-TRIALS | DOUBLE-BLIND | TYPE-18 | VIRUS-LIKE PARTICLES | PROPHYLACTIC EFFICACY | RANDOMIZED CONTROLLED-TRIAL | CERVICAL INTRAEPITHELIAL NEOPLASIA | Human papillomavirus 18 - immunology | Human papillomavirus 6 - immunology | Tumor Virus Infections - virology | Humans | Uterine Cervical Neoplasms - epidemiology | Genital Diseases, Female - prevention & control | Sexually Transmitted Diseases - epidemiology | Alphapapillomavirus - immunology | Human papillomavirus 16 - immunology | Sexually Transmitted Diseases - prevention & control | Young Adult | Adult | Female | Papillomavirus Infections - virology | Cervical Intraepithelial Neoplasia - epidemiology | Human papillomavirus 11 - immunology | Tumor Virus Infections - epidemiology | Papillomavirus Vaccines - administration & dosage | Genital Diseases, Female - virology | Papillomavirus Infections - complications | Global Health | Papanicolaou Test | Sexually Transmitted Diseases - virology | Papillomavirus Infections - epidemiology | Kaplan-Meier Estimate | Uterine Cervical Neoplasms - prevention & control | Vaginal Smears | Papillomavirus Vaccines - pharmacology | Tumor Virus Infections - prevention & control | Cervical Intraepithelial Neoplasia - virology | Tumor Virus Infections - complications | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Sexual Partners | Prevention | Complications and side effects | Care and treatment | Young women | Research | Health aspects | Papillomavirus infections | Risk factors | Genital diseases, Female | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Journal Article
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 34, Issue 39, pp. 4724 - 4731
Highlights • Affordable, safe & potent Measles vectored HPV vaccine developed & compared. • This vaccine found immunogenic similar to classical HPV protein... 
Allergy and Immunology | Prophylactic vaccine | Recombinant measles | HPV18L1 | Pichia expressed | HPV16L1 | MEDICINE, RESEARCH & EXPERIMENTAL | HUMORAL IMMUNE-RESPONSES | NEUTRALIZING ANTIBODIES | SINGLE | ASSAY | SAFETY | IMMUNOLOGY | TRIAL | GENETICALLY-MODIFIED MICE | WOMEN | VIRUS-LIKE PARTICLES | Immunogenicity, Vaccine | Papillomavirus Vaccines - classification | Immunoglobulin G - blood | Macaca mulatta | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Pichia | Animals | Immunity, Humoral | Recombinant Proteins - immunology | Capsid Proteins - immunology | Papillomavirus Vaccines - immunology | Oncogene Proteins, Viral - immunology | Antibodies, Neutralizing - blood | Measles virus | Primates | Vaccines | Papillomavirus infections | Recombinant proteins | Vaccination | Developing countries | Development and progression | Biological response modifiers | Prevention | Sexually transmitted diseases | Measles | Health aspects | Cervical cancer | Cancer | Antigens | Immunoglobulins | Cloning | Viruses | Infections | Genomes | RNA polymerase | Developing countries--LDCs | Proteins | Studies | Human papillomavirus | Plasmids | West Nile virus | NNSV, nonsegmented negative strand RNA virus | HPV, human papilloma virus | N, nucleocapsid protein | H, attachment protein | rMV, recombinant MV | F, fusion protein | MV, measles virus | M, matrix protein | EZ, Edmonston Zagreb strain | P, phosphoprotein | CC, cervical cancer | IC50, concentration that gives a response halfway between baseline and maximal | IL-5, interleukin 5 | IFN-ϒ, interferon gamma
Journal Article
Frontiers in immunology, ISSN 1664-3224, 2018, Volume 9, p. 1520
Lymphatic filariasis (LF) is a tropical parasitic infection of human transmitted by mosquitoes. Chronic infection results in severe physical disability in the... 
Journal Article
Science Translational Medicine, ISSN 1946-6234, 11/2014, Volume 6, Issue 261, pp. 261ra153 - 261ra153
A protective vaccine against hepatitis C virus (HCV) remains an unmet clinical need. HCV infects millions of people worldwide and is a leading cause of liver... 
MEDICINE, RESEARCH & EXPERIMENTAL | CHALLENGE | NEUTRALIZING ANTIBODIES | HEPATITIS-C VIRUS | SINGLE-SOURCE OUTBREAK | IMMUNE-RESPONSES | PERSISTENCE | STAGE MALARIA | CYTOKINE EXPRESSION | VIRAL CLEARANCE | ACUTE INFECTION | CELL BIOLOGY | Cell Proliferation | Hepacivirus - immunology | Viral Hepatitis Vaccines - administration & dosage | Humans | Viral Vaccines - genetics | England | Hepacivirus - genetics | Hepacivirus - pathogenicity | Healthy Volunteers | CD4-Positive T-Lymphocytes - immunology | Hepatitis C - immunology | Vaccination - methods | Time Factors | Hepatitis C Antibodies - blood | Adenoviridae - genetics | Adenoviridae - immunology | CD4-Positive T-Lymphocytes - virology | Hepatitis C - prevention & control | Interferon-gamma Release Tests | Lymphocyte Activation | Cells, Cultured | Histocompatibility Antigens Class I - immunology | Treatment Outcome | Enzyme-Linked Immunospot Assay | Pan troglodytes | Viral Vaccines - administration & dosage | Hepatitis C - diagnosis | Viral Hepatitis Vaccines - immunology | Animals | CD8-Positive T-Lymphocytes - virology | Hepatitis C - virology | Viral Hepatitis Vaccines - genetics | Immunologic Memory | CD8-Positive T-Lymphocytes - immunology | Viral Vaccines - immunology | modified vaccinia Ankara | Hepatitis | Prophylactic | Adenoviral | HCV | Vaccine | Hepatitis C Virus
Journal Article